Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Si-Bone (SIBN)
:SIBN
SIBN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.70 - $20.74
Previous CloseN/A
Volume50.81K
Average Volume (3M)342.63K
Market Cap
$754.89M
Enterprise Value$472.57M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Feb 24, 2025EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding41,938,180
10 Day Avg. Volume382,583
30 Day Avg. Volume342,631
Standard Deviation0.15
R-Squared0.17
Alpha-0.00624
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.81
Price to Cash Flow (P/CF)624.90
P/FCF Ratio0.00
Enterprise Value/Market Cap0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.32
Enterprise Value/Ebitda-16.22
Forecast
1Y Price Target
$20.00Price Target Upside11.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
SI-Bone News
PremiumCompany Announcements
SI-BONE Reports Strong Q3 Growth and Optimistic Outlook
---
Bulls Say, Bears Say
Bulls Say
Financial HealthManagement noted it achieved positive adjusted EBITDA in 4Q24.
Operational ExpansionSIBN ended the Q4 with ~1,390 active surgeons in the US, ~23% growth Y/Y and above expectations for 1,303.
Revenue PerformanceSI-Bone reported preliminary Q4/24 revenue of $48.8M-$49.0M, an increase of ~26% Y/Y, compared to CG/consensus estimates of $46.8M/$46.9M.
Bears Say
Guidance AdjustmentSIBN decreased the top line of its guidance for FY24 due to impacts from hurricane/IV fluid shortage, leading to cautious expectations for Q4.
Guidance RevisionSi-Bone lowered its FY24 guidance due to temporary procedure deferrals caused by an IV solution shortage.
Regulatory ConcernsSIBN disclosed a Civil Investigation Demand from the DOJ, although the rationale behind it is still unclear.
---
Ownership Overview
4.87% Insiders
28.87% Mutual Funds
13.88% Other Institutional Investors
40.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SIBN FAQ
What was Si-Bone’s price range in the past 12 months?
Si-Bone lowest stock price was $11.70 and its highest was $20.74 in the past 12 months.
What is Si-Bone’s market cap?
Si-Bone’s market cap is $754.89M.
When is Si-Bone’s upcoming earnings report date?
Si-Bone’s upcoming earnings report date is Feb 24, 2025 which is in 2 days.
How were Si-Bone’s earnings last quarter?
Si-Bone released its earnings results on Nov 12, 2024. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.239 by $0.079.
Is Si-Bone overvalued?
According to Wall Street analysts Si-Bone’s price is currently Undervalued.
Does Si-Bone pay dividends?
Si-Bone does not currently pay dividends.
What is Si-Bone’s EPS estimate?
Si-Bone’s EPS estimate is -0.15.
How many shares outstanding does Si-Bone have?
Si-Bone has 41,938,180 shares outstanding.
What happened to Si-Bone’s price movement after its last earnings report?
Si-Bone reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.239. Following the earnings report the stock price went down -15.931%.
Which hedge fund is a major shareholder of Si-Bone?
Currently, no hedge funds are holding shares in SIBN
---
SI-Bone Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.00 (11.11% Upside)
$20.00 (11.11% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.46%
12-Months-Change
Fundamentals
Return on Equity
-22.09%
Trailing 12-Months
Asset Growth
-1.68%
Trailing 12-Months
Company Description
Si-Bone
SI-BONE, Inc. is a medical device company, which engages in the research and development of minimally invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.
---
SIBN Company Deck
---
SIBN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and profitability improvements, driven by new product launches and increased physician engagement. Despite challenges like Hurricane Helene and scheduling issues, the company remains optimistic about future growth.Read More>---
SIBN Stock 12 Month Forecast
Average Price Target
$20.00
▲(11.11% Upside)
Technical Analysis
Best Analysts Covering SIBN
1 Year
1 Year Success Rate
14/32 ratings generated profit
1 Year Average Return
+0.04%
reiterated a buy rating last month
Copying David Saxon's trades and holding each position for 1 Year would result in 43.75% of your transactions generating a profit, with an average return of +0.04% per trade.
---